Catalyst Pharmaceutical
CPRX
CPRX
52 hedge funds and large institutions have $78.7M invested in Catalyst Pharmaceutical in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
12
Reduced
10
Closed
13
Calls
$1.54M
Puts
$656K
Net Calls
+$883K
Net Calls Change
+$816K
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$22.3M |
| 2 |
2
Morgan Stanley
New York
|
$4.1M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$2.28M |
| 4 |
TC
4
TFS Capital
West Chester,
Pennsylvania
|
$760K |
| 5 |
5
Renaissance Technologies
New York
|
$652K |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
PA
2
Perceptive Advisors
New York
|
$0 |
| 3 |
BC
3
Broadfin Capital
New York
|
$4.65M |
| 4 |
SC
4
Sophrosyne Capital
New York
|
$0 |
| 5 |
OM
5
Opaleye Management
Boston,
Massachusetts
|
$3.24M |
